Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOWGet Free Report) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 3,800 shares, a growth of 322.2% from the September 30th total of 900 shares. Based on an average daily volume of 18,600 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily volume of 18,600 shares, the days-to-cover ratio is currently 0.2 days.

Cardio Diagnostics Price Performance

Shares of CDIOW opened at $0.02 on Thursday. Cardio Diagnostics has a 1 year low of $0.01 and a 1 year high of $0.18. The firm has a fifty day moving average of $0.02 and a 200-day moving average of $0.02.

About Cardio Diagnostics

(Get Free Report)

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

Featured Articles

Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.